Skip to main content
. 2019 Apr 19;2(4):e192589. doi: 10.1001/jamanetworkopen.2019.2589

Figure 2. Sequence of Concurrent Sipuleucel-T Treatment.

Figure 2.

Treatment courses for patients identified as receiving sipuleucel-T treatment concurrently with another therapy for metastatic castration-resistant prostate cancer. Each row represents and individual patient.